Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer
Tito A. Sandoval(Cornell University), Juan R. Cubillos‐Ruiz(Cornell University)
Cited by 23
Related Papers
IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity
|Nature|2018|402
Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer
|Cancer Research|2026|2
Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer
|Research Square|2023|1